Movement Disorders

Cover image for Movement Disorders

May 1995

Volume 10, Issue 3

Pages fmi–fmi, 241–411

  1. Masthead

    1. Top of page
    2. Masthead
    3. Reviews
    4. Articles
    5. Brief Reports
    6. Communications
    7. Letters to the Editor
    8. Abstracts
    9. Announcement
    10. Erratum
    1. Masthead (page fmi)

      Article first published online: 12 OCT 2004 | DOI: 10.1002/mds.870100301

  2. Reviews

    1. Top of page
    2. Masthead
    3. Reviews
    4. Articles
    5. Brief Reports
    6. Communications
    7. Letters to the Editor
    8. Abstracts
    9. Announcement
    10. Erratum
    1. L-Dihydroxyphenylalanine and its decarboxylase: New ideas on their neuroregulatory roles (pages 241–249)

      Dr. Jolanta Opacka-Juffry and David J. Brooks

      Article first published online: 12 OCT 2004 | DOI: 10.1002/mds.870100302

  3. Articles

    1. Top of page
    2. Masthead
    3. Reviews
    4. Articles
    5. Brief Reports
    6. Communications
    7. Letters to the Editor
    8. Abstracts
    9. Announcement
    10. Erratum
    1. What is it?. Case 1, 1995: Psychosis, dementia, chorea, ataxia, and supranuclear gaze dysfunction (pages 257–262)

      Lisa M. Shulman, Anthony E. Lang, Joseph Jankovic, Noble J. David and Dr. William J. Weiner

      Article first published online: 12 OCT 2004 | DOI: 10.1002/mds.870100304

    2. Teaching tape for the motor section of the unified Parkinson's disease rating scale (pages 263–266)

      Dr. Christopher G. Goetz, Glenn T. Stebbins, Teresa A. Chmura, Stanley Fahn, Harold L. Klawans and C. David Marsden

      Article first published online: 12 OCT 2004 | DOI: 10.1002/mds.870100305

    3. Abnormalities of tracking behavior in Parkinson's disease (pages 267–276)

      Dr. Andreas Hufschmidt and Carl-Herrmann Lücking

      Article first published online: 12 OCT 2004 | DOI: 10.1002/mds.870100306

    4. CYP2D6-debrisoquine hydroxylase gene polymorphism in multiple system atrophy (pages 277–278)

      V. Planté-Bordeneuve, O. Bandmann, G. Wenning, N. P. Quinn, S. E. Daniel and Prof. A. E. Harding

      Article first published online: 12 OCT 2004 | DOI: 10.1002/mds.870100307

    5. n-Hexane-induced parkinsonism: Pathogenetic hypotheses (pages 279–282)

      Dr. G. Pezzoli, A. Antonini, S. Barbieri, M. Canesi, L. Perbellini, A. Zecchinelli, C. B. Mariani, A. Bonetti and K. L. Leenders

      Article first published online: 12 OCT 2004 | DOI: 10.1002/mds.870100308

    6. The anterior olfactory nucleus in Parkinson's disease (pages 283–287)

      R. K. B. Pearce, C. H. Hawkes and Dr. S. E. Daniel

      Article first published online: 12 OCT 2004 | DOI: 10.1002/mds.870100309

    7. “Pure” striatonigral degeneration and Parkinson's disease: A comparative clinical study (pages 288–294)

      Dr. Neziha Gouider-Khouja, Marie Vidailhet, Anne-Marie Bonnet, Jacques Pichon and Yves Agid

      Article first published online: 12 OCT 2004 | DOI: 10.1002/mds.870100310

    8. L-Dihydroxyphenylalanine and complex I deficiency in Parkinson's disease brain (pages 295–297)

      J. M. Cooper, S. E. Daniel, C. D. Marsden and Prof. A. H. V. Schapira

      Article first published online: 12 OCT 2004 | DOI: 10.1002/mds.870100311

    9. A probe for intracerebral aromatic amino-acid decarboxylase activity: Distribution and kinetics of [18F]6-fluoro-L-m-tyrosine in the human brain (pages 298–304)

      Dr. Claude Nahmias, Lindi Wahl, Raman Chirakal, Gunter Firnau and E. Stephen Garnett

      Article first published online: 12 OCT 2004 | DOI: 10.1002/mds.870100312

    10. Neuronal loss from the subthalamic nuclei in a patient with progressive chorea (pages 305–311)

      John H. Sinard and Dr. John C. Hedreen

      Article first published online: 12 OCT 2004 | DOI: 10.1002/mds.870100313

    11. Antiparkinsonian therapies and brain mitochondrial complex I activity (pages 312–317)

      Dr. Serge Przedborski, Vernice Jackson-Lewis and Stanley Fahn

      Article first published online: 12 OCT 2004 | DOI: 10.1002/mds.870100314

    12. Statistical prediction of the optimal site for thalamotomy in parkinsonian tremor (pages 318–328)

      Dr. F. A. Lenz, S. L. Normand, H. C. Kwan, D. Andrews, L. H. Rowland, M. W. Jones, M. Seike, Y. C. Lin, R. R. Tasker, J. O. Dostrovsky and Y. E. Lenz

      Article first published online: 12 OCT 2004 | DOI: 10.1002/mds.870100315

    13. Mood and anxiety fluctuation in Parkinson's disease associated with levodopa infusion: Preliminary findings (pages 329–332)

      Dr. Robert A. Maricle, John G. Nutt and Julie H. Carter

      Article first published online: 12 OCT 2004 | DOI: 10.1002/mds.870100316

  4. Brief Reports

    1. Top of page
    2. Masthead
    3. Reviews
    4. Articles
    5. Brief Reports
    6. Communications
    7. Letters to the Editor
    8. Abstracts
    9. Announcement
    10. Erratum
    1. “Off” painful dystonia in Parkinson's disease treated with botulinum toxin (pages 333–336)

      Dr. C. Pacchetti, G. Albani, E. Martignoni, L. Godi, E. Alfonsi and G. Nappi

      Article first published online: 12 OCT 2004 | DOI: 10.1002/mds.870100317

    2. Beneficial effect of intranasal desmopressin for nocturnal polyuria in Parkinson's disease (pages 337–340)

      Dr. Oksana Suchowersky, Sarah Furtado and Gina Rohs

      Article first published online: 12 OCT 2004 | DOI: 10.1002/mds.870100318

    3. Lid opening apraxia is associated with medial frontal hypometabolism (pages 341–344)

      D. Smith, T. Ishikawa, V. Dhawan, J. S. Winterkorn and Dr. D. Eidelberg

      Article first published online: 12 OCT 2004 | DOI: 10.1002/mds.870100319

    4. Longitudinal evolution of prefrontal leucotomy in Tourett's syndrome (pages 345–348)

      Dr. Jaime Kulisevsky, Marcelo L. Berthier and Asunción Avila

      Article first published online: 12 OCT 2004 | DOI: 10.1002/mds.870100320

    5. Effects of tolcapone in Parkinson's patients taking L-dihydroxyphenylalanine/carbidopa and selegiline (pages 349–351)

      Dr. T. L. Davis, M. Roznoski and R. S. Burns

      Article first published online: 12 OCT 2004 | DOI: 10.1002/mds.870100321

  5. Communications

    1. Top of page
    2. Masthead
    3. Reviews
    4. Articles
    5. Brief Reports
    6. Communications
    7. Letters to the Editor
    8. Abstracts
    9. Announcement
    10. Erratum
    1. Selegiline, fluoxetine, and depression in Parkinson's disease (page 352)

      Juan Carlos Garcia-Monco, Angel Padierna and Marian Gomez Beldarrain

      Article first published online: 12 OCT 2004 | DOI: 10.1002/mds.870100322

    2. Acute dystonic reaction to ecstasy (page 353)

      Alberto Priori, Laura Bertolasi, Alfredo Berardelli and Mario Manfredi

      Article first published online: 12 OCT 2004 | DOI: 10.1002/mds.870100323

    3. Diabetes mellitus presenting as paroxysmal kinesigenic dystonic choreoathetosis (pages 353–355)

      John D. Clark, Rajesh Pahwa, William C. Koller and David Morales

      Article first published online: 12 OCT 2004 | DOI: 10.1002/mds.870100324

    4. Does fluoxetine aggravate Parkinson's disease? A pilot prospective study (pages 355–357)

      Jean-Louis Montastruc, Nelly Fabre, Olivier Blin, Jean-Michel Senard, Olivier Rascol and André Rascol

      Article first published online: 12 OCT 2004 | DOI: 10.1002/mds.870100325

    5. Botulinum toxin treatment is not effective for epilepsy partialis continua (pages 357–358)

      Daniel Tarsy and Steven C. Schachter

      Article first published online: 12 OCT 2004 | DOI: 10.1002/mds.870100326

  6. Letters to the Editor

    1. Top of page
    2. Masthead
    3. Reviews
    4. Articles
    5. Brief Reports
    6. Communications
    7. Letters to the Editor
    8. Abstracts
    9. Announcement
    10. Erratum
    1. Letter to the editor (pages 359–360)

      Peter Vieregge and Ilse Heberlein

      Article first published online: 12 OCT 2004 | DOI: 10.1002/mds.870100327

  7. Abstracts

    1. Top of page
    2. Masthead
    3. Reviews
    4. Articles
    5. Brief Reports
    6. Communications
    7. Letters to the Editor
    8. Abstracts
    9. Announcement
    10. Erratum
    1. International conference on botulinum toxin: Basic science and clinical therapeutics (page 361)

      M.D. Mitchell F. Brin

      Article first published online: 12 OCT 2004 | DOI: 10.1002/mds.870100328

    2. Main lectures/platforms presentations (pages 362–370)

      Article first published online: 12 OCT 2004 | DOI: 10.1002/mds.870100329

    3. Poster presentations. Wednesday, June 14, 1995 (pages 371–381)

      Article first published online: 12 OCT 2004 | DOI: 10.1002/mds.870100330

    4. Poster presentations thursday. June 15, 1995 (pages 382–392)

      Article first published online: 12 OCT 2004 | DOI: 10.1002/mds.870100331

    5. Poster presentations. Friday, June 16, 1995 (pages 393–404)

      Article first published online: 12 OCT 2004 | DOI: 10.1002/mds.870100332

  8. Announcement

    1. Top of page
    2. Masthead
    3. Reviews
    4. Articles
    5. Brief Reports
    6. Communications
    7. Letters to the Editor
    8. Abstracts
    9. Announcement
    10. Erratum
    1. Announcement (pages 409–410)

      Article first published online: 12 OCT 2004 | DOI: 10.1002/mds.870100333

  9. Erratum

    1. Top of page
    2. Masthead
    3. Reviews
    4. Articles
    5. Brief Reports
    6. Communications
    7. Letters to the Editor
    8. Abstracts
    9. Announcement
    10. Erratum
    1. You have free access to this content
      Erratum (page 411)

      Article first published online: 12 OCT 2004 | DOI: 10.1002/mds.870100334

SEARCH

SEARCH BY CITATION